Status:
COMPLETED
Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Alveolar Soft Part Sarcoma
Sarcoma
Eligibility:
All Genders
4+ years
Brief Summary
Background: Alveolar soft part sarcoma (ASPS) is a rare tumor. ASPS is resistant to chemotherapy and radiation. ASPS is characterized by slow growth. Currently no in vitro or in vivo models of ASP...
Detailed Description
Background: Alveolar soft part sarcoma (ASPS) is a rare tumor. ASPS is resistant to chemotherapy and radiation. ASPS is characterized by slow growth. Currently no in vitro or in vivo models of ASP...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Subjects of any age with a diagnosis of primary or metastatic alveolar soft part sarcoma who are undergoing medically indicated surgery for their disease.
- EXCLUSION CRITERIA:
- None.
Exclusion
Key Trial Info
Start Date :
April 7 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 12 2012
Estimated Enrollment :
99999 Patients enrolled
Trial Details
Trial ID
NCT00340353
Start Date
April 7 2005
End Date
April 12 2012
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892